Stay updated on DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab

Sign up to get notified when there's something new on the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page.
Latest website image capture
Clouds background image

Latest updates to the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision v3.3.2 was added to the history and revision v3.3.1 was removed; no study data or primary page content appears to be affected.
    Difference
    0.1%
    Check dated 2025-12-01T16:43:41.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A new revision entry v3.3.1 was added and an earlier revision v3.2.0 was removed from the Record History.
    Difference
    0.1%
    Check dated 2025-11-24T12:38:25.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Removed the government funding/operating status notice, so the page no longer displays the banner about potential delays and links to cc.nih.gov and opm.gov. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-17T06:21:28.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Two new versions (2023-11-14 and 2025-03-07) were added to the Record History, capturing updates to Recruitment Status, Study Status, and Contacts/Locations.
    Difference
    0.1%
    Check dated 2025-11-03T00:55:08.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).
    Difference
    12%
    Check dated 2025-10-05T09:58:23.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The page updates the software revision from v3.0.2 to v3.1.0, indicating a new release with potential feature/fix changes.
    Difference
    0.3%
    Check dated 2025-09-28T03:11:48.000Z thumbnail image

Stay in the know with updates to DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab

Enter your email address, and we'll notify you when there's something new on the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page.